Clinical Trials Logo

Gastric or Duodenal Ulcers clinical trials

View clinical trials related to Gastric or Duodenal Ulcers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05959486 Completed - Clinical trials for Gastric or Duodenal Ulcers

A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fasting Conditions in Healthy Adult Volunteers

Start date: July 14, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this clinical trial is to evaluate the pharmacokinetics and safety between single administration of "BR6002" and coadministration of "BR6002A" and "BR6002B" under fasting conditions in healthy adult volunteers

NCT ID: NCT03214094 Completed - Clinical trials for Gastric or Duodenal Ulcers

Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

Start date: September 1, 2016
Phase:
Study type: Observational

The purpose of this survey is to investigate the safety and effectiveness of long-term administration of vonoprazan tablets for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin.

NCT ID: NCT02099708 Completed - Clinical trials for Gastric or Duodenal Ulcers

Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Start date: October 2010
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) therapy for up to 12 months in the routine clinical setting in patients receiving oral non-steroidal anti-inflammatory drugs (NSAIDs)

NCT ID: NCT02099682 Completed - Clinical trials for Gastric or Duodenal Ulcers

Long-term Use of Takepron Capsules on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin

Start date: August 2010
Phase: N/A
Study type: Observational

The purpose of this study is to investigate the safety and efficacy of long-term administration of lansoprazole (Takepron) for up to 12 months in the routine clinical setting in patients receiving low-dose aspirin